Jalra-Trio Sustained Release Tablets 100Mg 10Mg 500Mg - Pack of 2
₹336
₹336
Final Price inclusive of all taxes
size
15 tablets
Product Information
Brand
MATOSHRI MEDICOSE
Country Of Origin
India
Ideal For
Triple Combination For Type 2 Diabetes Mellitus. Dpp-4 Inhibition, Sglt2 Inhibition, And Biguanide Action For Comprehensive Glycaemic Control.
Ingredients
Vildagliptin 100Mg, Dapagliflozin 10Mg, Metformin Hydrochloride 500Mg Sr
Pack Of
2
Type
Tablets
Product Description
- Key Ingredients: This Sustained-Release Formulation Combines Vildagliptin 100Mg, Dapagliflozin 10Mg, And Metformin Hydrochloride 500Mg In Each Tablet For Comprehensive Diabetes Management.
- Product Design: Pharmaceutical-Grade Tablets Manufactured By Usv Private Limited Under Schedule G Prescription Guidelines, Ensuring Quality And Safety Standards.
- User Experience: Sustained-Release Technology Provides Controlled Medication Delivery Throughout The Day, Designed For Convenient Once-Daily Dosing As Directed By A Physician.
- Versatile Occasion: Formulated For Oral Use In Adults As Part Of A Prescribed Diabetes Treatment Regimen Under Medical Supervision.
- Quality Assurance: Manufactured By Exemed Pharmaceuticals Following Strict Pharmaceutical Standards, With Clear Labeling Of Active Ingredients And Dosage Information.
- Ideal For: Prescription Medication Intended For Diabetic Patients Requiring Combination Therapy, To Be Kept Out Of Reach Of Children And Stored As Directed.
MATOSHRI MEDICOSE
MATOSHRI MEDICOSE offers quality healthcare essentials from prescription medications and vitamins to wellness products and comfort solutions for your everyday needs.
Contact Us
Call: +91 - 9594860054
WhatsApp: +91 - 9594860054
Customer Support Time: 24/7
Email: drwaghdiabetes@gmail.com
Address: Dr. Wagh Diabetes Center Doctor line Ghamodiya Factory Area Near Kalamandir opp Bokare Hospital , Maharashtra, Nanded, 431601